Search

A new immunotherapy approach involves engineering CAR T cells to produce proteins that treat lymphoma.

… Thursday, September 29, 2016 Summary Researchers have modified CAR T cells to produce a protein called HVEM that could treat lymphoma . When injected, the cells naturally zero in on the location of the cancer cells and churn out HVEM continuously for several days. This new immunotherapy approach could

Meet Tiffany Traina, a breast medical oncologist and the Vice Chair of the Department of Medicine at Memorial Sloan Kettering.

… Friday, April 2, 2021 Summary Tiffany A. Traina, MD , is Vice Chair of the Department of Medicine and has been a medical oncologist on the Breast Medicine Service since 2006. She is also the Section Head of the Triple Negative Breast Cancer Clinical Research Program in which she works to develop new

The presence of inflammatory molecules in the cerebrospinal fluid appears to be causing many of the neurologic effects seen in people with COVID-19.

… Monday, February 8, 2021 Summary A unique collaboration among experts from several areas within MSK leads to findings about how inflammation appears to be driving the neurologic effects seen in some COVID-19 patients. One of the dozens of unusual symptoms that have emerged in COVID-19 patients is a condition

Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation are proud to announce today that 13 distinguished MSK nurses and one nursing team were recognized with the 2022 Robbins Family Award for Nursing Excellence. During National Nurses Week (May 6 – 12), MSK recognizes outstanding nurses for exemplary service.

… Wednesday, May 11, 2022 Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation are proud to announce today that 13 distinguished MSK nurses and one nursing team were recognized with the 2022 Robbins Family Award for Nursing Excellence. During National Nurses Week (May 6 – 12),

Numerous developments in cellular therapy, multiple myeloma, leukemia and lymphoma are being presented by Memorial Sloan Kettering Cancer Center (MSK) researchers at the American Society of Hematology (ASH) Annual Meeting, which runs December 10-13.

… Tuesday, December 6, 2022 Numerous developments in cellular therapy, multiple myeloma, leukemia, and lymphoma are being presented by Memorial Sloan Kettering Cancer Center (MSK) researchers at the American Society of Hematology (ASH) Annual Meeting , which runs December 10-13. Below are some highlights

MSK has expanded its bladder cancer surgery options with new robotic methods for constructing a substitute bladder.

… Friday, April 13, 2018 Summary One treatment for bladder cancer is the removal of the bladder and the creation of a substitute. The surgery is called a radical cystectomy, and the bladder-like substitute is a neobladder. This procedure has been a special challenge for robotic surgery. Now MSK offers

Gerstner Sloan Kettering recognizes student research by annually awarding the Grayer Fellowships, the Olayan Fellowship, the Robert B. Catell Fellowship, the Palestin Fellowship, and the Geoffrey Beene Graduate Student Fellowships.

… Thursday, September 12, 2019 Summary Student stipends at the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences are supported by a variety of sources, including philanthropic fellowships. Every year, GSK awards fellowships to two third-year students and six second-year students based

As we reflect in this season of gratitude, MSK Kids, the pediatric cancer program at Memorial Sloan Kettering, is grateful for our pediatric patients and their families. Patients just like Rihanna.

… Tuesday, November 24, 2020 MSK Kid, Rihanna, and her family visit New York City to see her billboard. MSK Kid, Rihanna, and her family visit New York City to see her billboard. MSK Kid, Rihanna, and her family visit New York City to see her billboard. MSK Kid, Rihanna, and her family visit New York City

Memorial Sloan Kettering has named three winners of this year’s Paul Marks Prize for Cancer Research, an award that recognizes promising investigators.

… Friday, November 8, 2019 Summary The Paul Marks Prize for Cancer Research, first awarded in 2001, recognizes promising scientists who have made important contributions to the study of cancer. Memorial Sloan Kettering has named three investigators as the recipients of this year’s Paul Marks Prize for

Learn how CAR T cell therapy and the expertise of MSK gave Guillaume Arnould another option for treating multiple myeloma, after other therapies failed.

… Tuesday, November 7, 2023 Shortly after finding out his wife was pregnant with their son, Guillaume Arnould got terrible news about his own health: He had multiple myeloma , a rare blood cancer. He was just 33 years old. The following six years were a grueling succession of stem cell transplants stem